Kai Tsao, MD, on Smoking Cessation in Patients with Cancer

November 27, 2020
Hannah Slater

Given that smoking is one of the major risk factors for recurrence of any cancer, Tsao explained that it's crucial that providers focus on smoking cessation in patients with cancer.

The Ruttenberg Treatment Center is one of several Mount Sinai cancer treatment sites that have begun a National Cancer Institute-funded smoking cessation program for all patients with cancer who answer yes to smoking or second-hand smoke questions during their intake appointment.

With the advent of this new program, patients who fit the aforementioned description will immediately be given state smoking cessation program information or placed into the Mount Sinai cessation program.

Given that smoking is one of the major risk factors for recurrence of any cancer, programs which promote smoking cessation may be particularly important for successful cancer treatment. In an interview with CancerNetwork®, Kai Tsao, MD, medical director of the Ruttenberg Treatment Center at the Tisch Cancer Institute at Mount Sinai and the program’s primary investigator, explained the importance of focusing on smoking cessation in patients with cancer and what programs like that offered at Mount Sinai can offer patients and health care providers.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.